Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
60
HRASF Quote, Financials, Valuation and Earnings
Last price:
$3.64
Seasonality move
:
-1.46%
Day range:
$3.64 - $3.64
52-week range:
$2.82 - $3.67
Dividend yield:
4.73%
P/E ratio:
9.75x
P/S ratio:
0.35x
P/B ratio:
1.26x
Volume:
--
Avg. volume:
--
1-year change:
29.2%
Market cap:
$5.3B
Revenue:
$14.1B
EPS (TTM):
$0.37
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1B | $12.3B | $21B | $16.7B | $14.1B | |
| Revenue Growth (YoY) | 4.47% | 51.87% | 70.68% | -20.39% | -15.28% | |
| Cost of Revenues | $4.4B | $8.4B | $18.3B | $11.8B | $8.3B | |
| Gross Profit | $3.7B | $3.9B | $2.7B | $4.9B | $5.8B | |
| Gross Profit Margin | 45.74% | 31.81% | 12.9% | 29.13% | 41.16% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $14.4M | $48.3M | $45.9M | $61.3M | $69.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.1B | $3.2B | $2.1B | $3.9B | $4.9B | |
| Operating Income | $637M | $741M | $573.3M | $926.4M | $915.5M | |
| Net Interest Expenses | $129.5M | $233M | $157.6M | $166.4M | $142M | |
| EBT. Incl. Unusual Items | $496.3M | $481.4M | $431.1M | $710.6M | $796.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $127.7M | $40.5M | $109.2M | $187.5M | $216.8M | |
| Net Income to Company | $496.3M | $481.4M | $431.1M | $710.6M | $796.8M | |
| Minority Interest in Earnings | -$23M | -$46.4M | -$52.8M | -$45.3M | -$44.8M | |
| Net Income to Common Excl Extra Items | $345.7M | $394.6M | $269.1M | $477.9M | $535.2M | |
| Basic EPS (Cont. Ops) | $0.24 | $0.27 | $0.18 | $0.33 | $0.37 | |
| Diluted EPS (Cont. Ops) | $0.24 | $0.27 | $0.18 | $0.33 | $0.37 | |
| Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B | |
| Weighted Average Diluted Share | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B | |
| EBITDA | $1.2B | $1.2B | $1.1B | $1.4B | $1.6B | |
| EBIT | $638.2M | $613.6M | $552.8M | $883.2M | $967.7M | |
| Revenue (Reported) | $8.1B | $12.3B | $21B | $16.7B | $14.1B | |
| Operating Income (Reported) | $637M | $741M | $573.3M | $926.4M | $915.5M | |
| Operating Income (Adjusted) | $638.2M | $613.6M | $552.8M | $883.2M | $967.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $6B | $6B | $3.7B | $4.5B | |
| Revenue Growth (YoY) | 20.67% | 117.74% | 1.43% | -39.48% | 24.27% | |
| Cost of Revenues | $1.4B | $4.8B | $4.7B | $2B | $2.8B | |
| Gross Profit | $1.3B | $1.1B | $1.3B | $1.7B | $1.7B | |
| Gross Profit Margin | 47.34% | 19.17% | 22.23% | 45.71% | 37.71% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1B | $895.7M | $990.5M | $1.4B | $1.5B | |
| Operating Income | $268.8M | $247M | $353.5M | $267.1M | $260.1M | |
| Net Interest Expenses | $38.6M | $36.4M | $50.6M | $39M | $18.4M | |
| EBT. Incl. Unusual Items | $234.1M | $213.9M | $305.8M | $231.3M | $246.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $65.1M | $59.2M | $84M | $64.7M | $73.9M | |
| Net Income to Company | $234.1M | $213.9M | $305.8M | $231.3M | $246.2M | |
| Minority Interest in Earnings | -$9.8M | -$12.7M | -$13M | -$11.1M | -$10.6M | |
| Net Income to Common Excl Extra Items | $159.3M | $141.9M | $208.8M | $155.4M | $161.7M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.10 | $0.14 | $0.11 | $0.11 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.10 | $0.14 | $0.11 | $0.11 | |
| Weighted Average Basic Share | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B | |
| Weighted Average Diluted Share | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B | |
| EBITDA | $465.4M | $434.8M | $571.6M | $497.3M | $488.1M | |
| EBIT | $298M | $262.1M | $384.6M | $311.3M | $308.4M | |
| Revenue (Reported) | $2.7B | $6B | $6B | $3.7B | $4.5B | |
| Operating Income (Reported) | $268.8M | $247M | $353.5M | $267.1M | $260.1M | |
| Operating Income (Adjusted) | $298M | $262.1M | $384.6M | $311.3M | $308.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.6B | $15.4B | $21B | $14.3B | $15B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.7B | $11.7B | $18.1B | $9.1B | $9.1B | |
| Gross Profit | $3.9B | $3.8B | $2.9B | $5.2B | $5.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.2B | $3.1B | $2.3B | $4.4B | $5B | |
| Operating Income | $671.1M | $720M | $684.8M | $837.6M | $906.5M | |
| Net Interest Expenses | $133.6M | $229.4M | $170.7M | $155M | $121.4M | |
| EBT. Incl. Unusual Items | $526.8M | $464.5M | $529.1M | $633.7M | $808.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $133.9M | $34.5M | $136M | $167.6M | $225.2M | |
| Net Income to Company | $528.5M | $461.2M | $523M | $636.1M | $811.8M | |
| Minority Interest in Earnings | -$26.4M | -$49.4M | -$52.7M | -$43.3M | -$44.3M | |
| Net Income to Common Excl Extra Items | $366.6M | $380.6M | $340.4M | $422.8M | $539.3M | |
| Basic EPS (Cont. Ops) | $0.25 | $0.26 | $0.23 | $0.29 | $0.37 | |
| Diluted EPS (Cont. Ops) | $0.25 | $0.26 | $0.23 | $0.29 | $0.37 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.3B | $1.3B | $1.3B | $1.6B | $1.7B | |
| EBIT | $680M | $584.2M | $683.6M | $808.6M | $965.4M | |
| Revenue (Reported) | $8.6B | $15.4B | $21B | $14.3B | $15B | |
| Operating Income (Reported) | $671.1M | $720M | $684.8M | $837.6M | $906.5M | |
| Operating Income (Adjusted) | $680M | $584.2M | $683.6M | $808.6M | $965.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $6B | $6B | $3.7B | $4.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $4.8B | $4.7B | $2B | $2.8B | |
| Gross Profit | $1.3B | $1.1B | $1.3B | $1.7B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1B | $895.7M | $990.5M | $1.4B | $1.5B | |
| Operating Income | $268.8M | $247M | $353.5M | $267.1M | $260.1M | |
| Net Interest Expenses | $38.6M | $36.4M | $50.6M | $39M | $18.4M | |
| EBT. Incl. Unusual Items | $234.1M | $213.9M | $305.8M | $231.3M | $246.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $65.1M | $59.2M | $84M | $64.7M | $73.9M | |
| Net Income to Company | $234.1M | $213.9M | $305.8M | $231.3M | $246.2M | |
| Minority Interest in Earnings | -$9.8M | -$12.7M | -$13M | -$11.1M | -$10.6M | |
| Net Income to Common Excl Extra Items | $159.3M | $141.9M | $208.8M | $155.4M | $161.7M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.10 | $0.14 | $0.11 | $0.11 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.10 | $0.14 | $0.11 | $0.11 | |
| Weighted Average Basic Share | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B | |
| Weighted Average Diluted Share | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B | |
| EBITDA | $465.4M | $434.8M | $571.6M | $497.3M | $488.1M | |
| EBIT | $298M | $262.1M | $384.6M | $311.3M | $308.4M | |
| Revenue (Reported) | $2.7B | $6B | $6B | $3.7B | $4.5B | |
| Operating Income (Reported) | $268.8M | $247M | $353.5M | $267.1M | $260.1M | |
| Operating Income (Adjusted) | $298M | $262.1M | $384.6M | $311.3M | $308.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $1B | $2.1B | $1.5B | $1.4B | |
| Short Term Investments | $185.2M | $53.1M | $43.9M | $72.8M | $42.9M | |
| Accounts Receivable, Net | $1.3B | $1.6B | $1.6B | $2.7B | $1.5B | |
| Inventory | $211.2M | $416.7M | $1.1B | $219.4M | $174.9M | |
| Prepaid Expenses | $124.3M | $215.3M | $95.8M | $121.8M | $134.9M | |
| Other Current Assets | $89.3M | $83M | $128.3M | $94.3M | $85.3M | |
| Total Current Assets | $4.6B | $7.3B | $9.9B | $7.3B | $6.5B | |
| Property Plant And Equipment | $2.5B | $2.3B | $2.2B | $2.4B | $2.3B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $999.7M | $954.3M | $909.5M | $1B | $970.9M | |
| Other Intangibles | $4.8B | $4.7B | $4.7B | $5.2B | $5.1B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $13.6B | $15.9B | $18.4B | $16.7B | $15.7B | |
| Accounts Payable | $758.6M | $2.7B | $3.3B | $2.9B | $2.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $24.7M | $49.1M | $22.8M | $27.1M | $25.4M | |
| Other Current Liabilities | $108.5M | $152.8M | $162M | $186.3M | $178.7M | |
| Total Current Liabilities | $4.1B | $6.9B | $7.3B | $6.6B | $6.2B | |
| Long-Term Debt | $3.8B | $3.5B | $5.5B | $4.5B | $4.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.7B | $12B | $14.4B | $12.5B | $11.5B | |
| Common Stock | $1.8B | $1.7B | $1.6B | $1.6B | $1.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $3.6B | $3.6B | $3.6B | $3.8B | $3.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $239.2M | $245.2M | $264.1M | $346.4M | $319.2M | |
| Total Equity | $3.9B | $3.9B | $3.9B | $4.1B | $4.1B | |
| Total Liabilities and Equity | $13.6B | $15.9B | $18.4B | $16.7B | $15.7B | |
| Cash and Short Terms | $1.4B | $1.1B | $2.1B | $1.5B | $1.4B | |
| Total Debt | $4.4B | $3.7B | $6B | $5.1B | $4.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $882.5M | $2.3B | $1.3B | $2B | |
| Short Term Investments | $29.5M | $32.1M | $38.5M | $67.7M | $77.9M | |
| Accounts Receivable, Net | $2.6B | $3.9B | $3.5B | $3.6B | $3.4B | |
| Inventory | $146.5M | $407M | $950.3M | $669.4M | $86.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $535M | $599.8M | $749.2M | $767.7M | $1.1B | |
| Total Current Assets | $4.9B | $8.3B | $8.5B | $6.8B | $7.1B | |
| Property Plant And Equipment | $2.4B | $2.2B | $2.3B | $2.3B | $2.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $952.8M | $940.8M | $946.7M | $981.3M | $1B | |
| Other Intangibles | $4.6B | $4.7B | $4.9B | $5.1B | $5.4B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $13.4B | $16.8B | $17.3B | $16B | $16.7B | |
| Accounts Payable | $1.7B | $3B | $2.9B | $2.5B | $2.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $21.7M | $24.3M | $22.5M | $25.2M | $25.8M | |
| Other Current Liabilities | $1.4B | $1.7B | $2B | $2B | $1.9B | |
| Total Current Liabilities | $4.3B | $7.7B | $6.7B | $6B | $6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.5B | $12.8B | $13.2B | $11.8B | $12.1B | |
| Common Stock | $1.7B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $237.4M | $250.9M | $302.1M | $348.8M | $344.7M | |
| Total Equity | $3.9B | $4B | $4.1B | $4.2B | $4.5B | |
| Total Liabilities and Equity | $13.4B | $16.8B | $17.3B | $16B | $16.7B | |
| Cash and Short Terms | $1.4B | $914.7M | $2.3B | $1.4B | $2.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $496.3M | $481.4M | $431.1M | $710.6M | $796.8M | |
| Depreciation & Amoritzation | $522M | $548.2M | $503.1M | $562.2M | $608.7M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $5.5M | -$1.1B | -$1.4B | -$88.7M | -$866.9M | |
| Change in Inventories | -$4.3M | -$232.7M | -$661.7M | $410.2M | $42.8M | |
| Cash From Operations | $1B | $1.2B | $37.6M | $1.7B | $923.2M | |
| Capital Expenditures | $578.3M | $696.5M | $748.2M | $883.2M | $931.1M | |
| Cash Acquisitions | -$53.2M | -$88.6M | -$56.2M | -$82.5M | -$36.3M | |
| Cash From Investing | -$592.3M | -$784M | -$799.8M | -$930.3M | -$870.9M | |
| Dividends Paid (Ex Special Dividend) | -$186.5M | -$228.4M | -$231.5M | -$258.9M | -$269.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $585.4M | $621.3M | $2.2B | $665.7M | $509.9M | |
| Long-Term Debt Repaid | -$23.9M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | -$939.1M | -$61.1M | -$1.8B | -$282.3M | |
| Cash From Financing | $285.8M | -$573M | $1.9B | -$1.4B | -$71M | |
| Beginning Cash (CF) | $415.7M | $1.2B | $933.9M | $2.1B | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $711.6M | -$120.1M | $1.1B | -$660M | -$18.6M | |
| Ending Cash (CF) | $1.1B | $1B | $2B | $1.4B | $1.4B | |
| Levered Free Cash Flow | $439.7M | $540.4M | -$710.6M | $819.4M | -$7.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $234.1M | $213.9M | $305.8M | $231.3M | $246.2M | |
| Depreciation & Amoritzation | $130.6M | $126.1M | $131M | $142.9M | $143.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$285.2M | -$698.6M | $549.6M | -$115.5M | -$18.7M | |
| Change in Inventories | $56.3M | $3.7M | $168.7M | $12.7M | $92.9M | |
| Cash From Operations | $327.6M | -$52.2M | $779.5M | $4.1M | $221.5M | |
| Capital Expenditures | $140.1M | $144.9M | $167.3M | $170.3M | $201.6M | |
| Cash Acquisitions | -$361.5K | -- | -$77.3M | -- | -$315.7K | |
| Cash From Investing | -$129.7M | -$138.9M | -$195.7M | -$130M | -$244.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -$3.6M | -$1.8M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $13.1M | -- | $544.1M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $82.9M | $125M | -$405M | $24.1M | $6.1M | |
| Cash From Financing | $62.3M | $84.6M | -$407M | $11.6M | $591.2M | |
| Beginning Cash (CF) | $1.2B | $993.7M | $2.1B | $1.4B | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $260.3M | -$106.5M | $176.9M | -$114.3M | $568M | |
| Ending Cash (CF) | $1.4B | $887.3M | $2.3B | $1.3B | $2B | |
| Levered Free Cash Flow | $187.5M | -$197M | $612.2M | -$166.2M | $19.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $528.5M | $461.2M | $523M | $636.1M | $811.8M | |
| Depreciation & Amoritzation | $534.8M | $543.7M | $508.1M | $574.1M | $609.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$122.9M | -$1.5B | -$102.4M | -$753.7M | -$770.1M | |
| Change in Inventories | $8.1M | -$285.3M | -$496.6M | $254.2M | $123M | |
| Cash From Operations | $1.2B | $857.1M | $869.4M | $927.2M | $1.1B | |
| Capital Expenditures | $613.6M | $701.3M | $770.7M | $886.2M | $962.4M | |
| Cash Acquisitions | -$23.6M | -$88.3M | -$133.5M | -$5.2M | -$36.6M | |
| Cash From Investing | -$576.1M | -$793.2M | -$856.6M | -$864.6M | -$985.6M | |
| Dividends Paid (Ex Special Dividend) | -$186.5M | -$231.9M | -$229.7M | -$257M | -$269.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $621.3M | $2.3B | $652.6M | $1.1B | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $82.9M | -$897M | -$591.1M | -$1.4B | -$300.3M | |
| Cash From Financing | $237.9M | -$550.7M | $1.4B | -$1B | $508.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $818.9M | -$486.9M | $1.4B | -$951.1M | $663.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $543.5M | $155.8M | $98.7M | $41M | $178.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $234.1M | $213.9M | $305.8M | $231.3M | $246.2M | |
| Depreciation & Amoritzation | $130.6M | $126.1M | $131M | $142.9M | $143.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$285.2M | -$698.6M | $549.6M | -$115.5M | -$18.7M | |
| Change in Inventories | $56.3M | $3.7M | $168.7M | $12.7M | $92.9M | |
| Cash From Operations | $327.6M | -$52.2M | $779.5M | $4.1M | $221.5M | |
| Capital Expenditures | $140.1M | $144.9M | $167.3M | $170.3M | $201.6M | |
| Cash Acquisitions | -$361.5K | -- | -$77.3M | -- | -$315.7K | |
| Cash From Investing | -$129.7M | -$138.9M | -$195.7M | -$130M | -$244.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -$3.6M | -$1.8M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $13.1M | -- | $544.1M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $82.9M | $125M | -$405M | $24.1M | $6.1M | |
| Cash From Financing | $62.3M | $84.6M | -$407M | $11.6M | $591.2M | |
| Beginning Cash (CF) | $1.2B | $993.7M | $2.1B | $1.4B | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $260.3M | -$106.5M | $176.9M | -$114.3M | $568M | |
| Ending Cash (CF) | $1.4B | $887.3M | $2.3B | $1.3B | $2B | |
| Levered Free Cash Flow | $187.5M | -$197M | $612.2M | -$166.2M | $19.9M | |
Get HRASF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HRASF
Sector
P/E ratio
9.75x
14.77x
PEG ratio
0.35x
0.35x
P/B ratio
1.26x
1.44x
Price / LTM sales
0.35x
1.58x
Growth Metrics
HRASF
Sector
Revenue growth
24.27%
2.79%
Earnings growth
3.72%
-0.57%
Revenue (5-year growth)
12.8%
4.48%
Earnings forecast
--
$0.39
Profitability
HRASF
Sector
Profitability FY 2024
$5.8B
$1.3B
Return on invested capital
8.71%
3.5%
Return on assets
3.44%
2.53%
Return on equity
12.77%
8.06%
Earnings Date
Last Earnings Date
Jul
17
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Oct
16
Balance Sheet
HRASF
Sector
Total cash
$2.1B
$406.3M
Short term investments
$42.9M
$97.6M
Total assets
$15.7B
$11.2B
Long term debt
--
$3.2B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 4.23% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 1.96% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.19% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
